Matches in Wikidata for { <http://www.wikidata.org/entity/Q90646316> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q90646316 description "artículu científicu espublizáu en marzu de 2020" @default.
- Q90646316 description "scientific article published on 25 March 2020" @default.
- Q90646316 description "wetenschappelijk artikel" @default.
- Q90646316 description "наукова стаття, опублікована 25 березня 2020" @default.
- Q90646316 name "PD-L1 expression and response to pembrolizumab in patients with EGFR-mutant non-small cell lung cancer" @default.
- Q90646316 name "PD-L1 expression and response to pembrolizumab in patients with EGFR-mutant non-small cell lung cancer" @default.
- Q90646316 type Item @default.
- Q90646316 label "PD-L1 expression and response to pembrolizumab in patients with EGFR-mutant non-small cell lung cancer" @default.
- Q90646316 label "PD-L1 expression and response to pembrolizumab in patients with EGFR-mutant non-small cell lung cancer" @default.
- Q90646316 prefLabel "PD-L1 expression and response to pembrolizumab in patients with EGFR-mutant non-small cell lung cancer" @default.
- Q90646316 prefLabel "PD-L1 expression and response to pembrolizumab in patients with EGFR-mutant non-small cell lung cancer" @default.
- Q90646316 P1433 Q90646316-79EA025F-1B33-429A-8AAB-40B7C9FB3E5C @default.
- Q90646316 P1476 Q90646316-082BF9BA-AF2A-4ABC-B987-08A5B573984B @default.
- Q90646316 P2093 Q90646316-0FCFCB86-6EFF-444A-B99A-9B7235FCA617 @default.
- Q90646316 P2093 Q90646316-129D0BA9-693D-4D7E-86B3-73DA03607017 @default.
- Q90646316 P2093 Q90646316-1FBB6EF8-C7AB-4A6E-8AF0-CFCF9BB5A112 @default.
- Q90646316 P2093 Q90646316-27BF8B48-50E9-4F72-BB5B-CD43582919BB @default.
- Q90646316 P2093 Q90646316-35101EDA-85D2-4660-A34C-B2AF051B6C29 @default.
- Q90646316 P2093 Q90646316-67507997-0A86-46BB-BD38-26893F63D8B4 @default.
- Q90646316 P2093 Q90646316-6D8086C6-CF06-463A-9A02-F3A69AD171C0 @default.
- Q90646316 P2093 Q90646316-7863C744-627A-48C8-BEE8-793173B9F4AC @default.
- Q90646316 P2093 Q90646316-C141B255-33E6-484E-9FB7-A5968EC5CBDE @default.
- Q90646316 P2093 Q90646316-DA587C37-714C-4507-BEEC-8D2506E8FB1B @default.
- Q90646316 P2093 Q90646316-E73A3FD3-49E9-4A1B-94EB-C8226C1AE001 @default.
- Q90646316 P2093 Q90646316-E94731FE-5D70-4AF4-A5B0-41EA2F787157 @default.
- Q90646316 P31 Q90646316-44571A71-4BF6-420A-9E44-F781D1257937 @default.
- Q90646316 P356 Q90646316-5424C7C0-EDC5-471D-B871-5F5EA7A6246C @default.
- Q90646316 P577 Q90646316-B0315A15-036D-47BB-A0B7-B4020921578C @default.
- Q90646316 P698 Q90646316-2195B495-BF10-4051-BA86-8D291B248155 @default.
- Q90646316 P921 Q90646316-0D69031A-86AA-4E14-970F-1BFA08AEE0F5 @default.
- Q90646316 P921 Q90646316-94FFA8E0-41A0-42F7-8429-95BEA5647B42 @default.
- Q90646316 P356 HYAA033 @default.
- Q90646316 P698 32211792 @default.
- Q90646316 P1433 Q2231629 @default.
- Q90646316 P1476 "PD-L1 expression and response to pembrolizumab in patients with EGFR-mutant non-small cell lung cancer" @default.
- Q90646316 P2093 "Akira Ono" @default.
- Q90646316 P2093 "Eriko Miyawaki" @default.
- Q90646316 P2093 "Haruki Kobayashi" @default.
- Q90646316 P2093 "Haruyasu Murakami" @default.
- Q90646316 P2093 "Hirotsugu Kenmotsu" @default.
- Q90646316 P2093 "Kazushige Wakuda" @default.
- Q90646316 P2093 "Keita Mori" @default.
- Q90646316 P2093 "Nobuaki Mamesaya" @default.
- Q90646316 P2093 "Shota Omori" @default.
- Q90646316 P2093 "Takahisa Kawamura" @default.
- Q90646316 P2093 "Tateaki Naito" @default.
- Q90646316 P2093 "Toshiaki Takahashi" @default.
- Q90646316 P31 Q13442814 @default.
- Q90646316 P356 "10.1093/JJCO/HYAA033" @default.
- Q90646316 P577 "2020-03-25T00:00:00Z" @default.
- Q90646316 P698 "32211792" @default.
- Q90646316 P921 Q13896859 @default.
- Q90646316 P921 Q3658562 @default.